The person-to-person transmission landscape of the gut and oral microbiomes
The person-to-person transmission landscape of the gut and oral microbiomes - (2023)
The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells
The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells - (2023)
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis - (2022)
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS - (2022)
“Love is a microbe too”: Microbiome dialectics
“Love is a microbe too”: Microbiome dialectics - (2022)
Modeling microbiota-associated human diseases: from minimal models to complex systems
Modeling microbiota-associated human diseases: from minimal models to complex systems - (2022)
Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments - (2022)
Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders
Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders - (2022)
